A recent meta-analysis suggested that DRD4 48 bp VNTR variants can be considered as ADHD biomarkers to support the diagnosis and to predict methylphenidate response in children (Bonvicini et al., 2020). The gene discussed is DRD4; the disease is attention deficit-hyperactivity disorder.